0QZU.L

Vertex Pharmaceuticals Incorporated
LSEUSDEQUITY DELAYED
Last price
551.27
▲ 11.60 (2.15%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
539.46
Prev close
539.67
Day high
555.00
Day low
546.00
Volume
4
Market cap
P/E (TTM)
0.58
52W range
290.87 – 555.00

Day trading desk

Current session · delayed
Gap from prior close
VWAP
547.92
+0.61% from price
Relative volume
0.15×
Quiet session
Session range
3.81%
539.46 – 560.00
Position in range
57%
Mid range
ATR (14D)
Daily true range
Prior day high
PDH
Prior day low
PDL
Bid / ask spread
Quote not published
Session volume
442
Avg 2.91K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 0QZU.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
532.27K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 21, 26
TATSIS OURANIA
Officer
STOCK 8.25K $0 Direct
Jul 21, 26
SACHDEV AMIT
Officer
STOCK 8.25K $0 Direct
Jul 2, 26
MCKECHNIE DUNCAN J.
Officer
SELL 1.54K $799.78K Direct
Jul 2, 26
TATSIS OURANIA
Officer
SELL 1.50K $787.49K Direct
Jul 1, 26
LIU JOY
Officer
SELL 828 $416.24K Direct
Jun 26, 26
BOZIC CARMEN
Officer
SELL 596 $287.57K Direct
Jun 18, 26
BOZIC CARMEN
Officer
SELL 1.02K $471.41K Direct
Jun 15, 26
BOZIC CARMEN
Officer
SELL 4.06K $1.83M Direct
Jun 5, 26
BOZIC CARMEN
Officer
SELL 1.75K $785.25K Direct
Jun 1, 26
LIU JOY
Officer
SELL 828 $364.25K Direct
May 29, 26
BOZIC CARMEN
Officer
SELL 1.97K $888.30K Direct
May 15, 26
BUNNAGE MARK E.
Officer
SELL 33 $14.96K Direct
May 15, 26
BOZIC CARMEN
Officer
SELL 1.35K $613.97K Direct
May 12, 26
BOZIC CARMEN
Officer
SELL 6.99K $3.14M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
ALTSHULER DAVID
Officer 34.48K Stock Award(Grant)
ARBUCKLE STUART A
Chief Operating Officer 100.75K Stock Award(Grant)
ATKINSON EDWARD MORROW III
Chief Technology Officer 18.43K Sale
KEWALRAMANI RESHMA
Chief Executive Officer 98.28K Sale
LEIDEN JEFFREY M
Officer and Director 38.78K Stock Award(Grant)
LIU JOY
Officer 19.13K Sale
SACHDEV AMIT
Officer 74.03K Stock Award(Grant)
SACHS BRUCE I
Director 45.00K Purchase
TATSIS OURANIA
Officer 53.57K Stock Award(Grant)
WAGNER CHARLES F JR
Chief Operating Officer 48.79K Stock Award(Grant)

Fundamentals

TTM · reported
Market cap
Enterprise value$133.32B
Revenue (TTM)$12.59B
Gross profit$6.92B
EBITDA$5.10B
Net income$4.41B
EPS (TTM)$9.48
Free cash flow$2.63B
Total cash$7.85B
Total debt$1.98B
Book value / share$79.92
Shares outstanding255.56M
Float252.68M
Short % of float
Dividend yield
Beta (5Y)0.31

Valuation & profitability ratios

Account required
Trailing P/E0.58
Forward P/E
PEG ratio
Price / sales
Price / book6.86
EV / revenue10.59
EV / EBITDA26.14
Gross margin54.96%
Operating margin38.05%
Profit margin35.00%
Return on equity23.54%
Return on assets11.93%
Debt / equity9.77
Current ratio3.19
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $3.39B +10.3%
Next quarter $3.49B +9.6%
Current year $13.20B +10.0%
Next year $14.62B +10.8%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders0.21%
Held by institutions98.12%
Institutions holding2.44K
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
EMA 12
EMA 26
EMA 50
RSI (14)
MACD (12,26,9)
Hist —
ATR (14)
Realised vol 30D
Annualised
Bollinger upper
20, 2σ
Bollinger lower
20, 2σ
50 / 200 cross
Trend bias

Options chain

Account required
ExpirySpot 551.27
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
Correlation to SPY
Realised vol 30D
Annualised
Market vol 1Y
SPY, annualised
Max drawdown 1Y
Peak to trough
Max drawdown 5Y
Peak to trough
ATR 14
Average true range
Beta (reported)
0.31
5Y monthly, from filing

Rating changes

552 on file
DateFirm ActionFromTo
Aug 5, 26 Truist Securities MAINTAINED Buy Buy
Aug 5, 26 Barclays MAINTAINED Overweight Overweight
Aug 4, 26 TD Cowen MAINTAINED Buy Buy
Aug 4, 26 Cantor Fitzgerald MAINTAINED Overweight Overweight
Aug 4, 26 Canaccord Genuity MAINTAINED Hold Hold
Jul 13, 26 UBS MAINTAINED Buy Buy
Jul 13, 26 Truist Securities MAINTAINED Buy Buy
Jul 7, 26 RBC Capital MAINTAINED Outperform Outperform
Jul 7, 26 Baird MAINTAINED Underperform Underperform
May 6, 26 Barclays MAINTAINED Overweight Overweight
May 5, 26 Canaccord Genuity MAINTAINED Hold Hold
May 5, 26 Morgan Stanley MAINTAINED Overweight Overweight

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.